Search Result "BRCA deficient"
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2008 Page: 426-430
Author(s): Rachel Litman, Rigu Gupta, Robert M. Brosh, Jr., Sharon B. Cantor
Inducing Synthetic Lethality using PARP Inhibitors
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 192-195
Author(s): David S. Boss, Jos H. Beijnen, Jan H.M. Schellens
Role of Genetic Factors in the Pathogenesis of Radial Deficiencies in Humans
Journal: Current Genomics
Volume: 16 Issue: 4 Year: 2015 Page: 264-278
Author(s): Amira Elmakky,Ilaria Stanghellini,Antonio Landi,Antonio Percesepe
BRCA Unclassified Variants: How Can They be Classified?
Journal: Current Women`s Health Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 30-37
Author(s): Stefania Tommasi, Simona De Summa, Brunella Pilato, Angelo Paradiso
PARP Inhibitors in Epithelial Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 2 Year: 2018 Page: 145-158
Author(s): Kristin N. Taylor,Ramez N. Eskander
PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Journal: Current Drug Targets
Volume: 19 Issue: 1 Year: 2018 Page: 21-37
Author(s): Dalia Kamel,Christopher Gray,Jagdeep Singh Walia,Vikaash Kumar
Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 6 Year: 2012 Page: 672-677
Author(s): Youngjin Park,Ayako Moriyama,Tomoaki Kitahara,Yutaka Yoshida,Tasuku Urita,Ryoji Kato
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Journal: Current Pharmacogenomics
Volume: 5 Issue: 4 Year: 2007 Page: 280-291
Author(s): Bernard Friedenson
Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 3 Year: 2014 Page: 3419-3454
Author(s): Jose Manuel Calderon-Montano, Estefania Burgos-Moron, Manuel Luis Orta, Miguel Lopez-Lazaro
Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions
Journal: Clinical Cancer Drugs
Volume: 5 Issue: 1 Year: 2018 Page: 3-12
Author(s): Gonzalo H. Giornelli,Pablo Mando